The University of Chicago

[ Search ][ The University of Chicago ][ Index ][ Comments ][ The Division of the Biological Sciences ][ The University of Chicago Hospitals ][ The University of Chicago ][ Copyright Information ]

Biological Sciences Division

 

 

 

 

Dominique Missiakas

A native of France, Dr. Missiakas received her Ph.D. in Biochemistry at the Université of Paris XI in Orsay, France (1991). She obtained subsequent post-doctoral training in bacterial genetics and physiology at the University of Utah (1992) and Geneva, Switzerland (1993). She served as a Maître Assistante at the Centre Medical Universitaire in Geneva from 1994-1995. She joined the Centre Nationale de Recherche Scientifique (Marseilles, France) as a Group leader in 1995. Dr. Missiakas received her habilitation in Microbiology from the Université de la Méditerranée (1997). In 1998, Dr. Missiakas was appointed Assistant Professor in the Department of Microbiology, Immunology and Molecular Genetics at the University of California, Los Angeles. Dr. Missiakas joined the Biological Sciences Division faculty at the University of Chicago in 2001.

Dr. Missiakas’ research program examines various protein secretion pathways of Staphylococcus aureus and Bacillus anthracis and their contribution to virulence. Recently, Dr. Missiakas and colleagues have shown that the human pathogen S. aureus secretes EsxA and EsxB across the bacterial envelope. Further, mutants that fail to secrete EsxA and EsxB display defects in the pathogenesis of S. aureus murine abscesses, suggesting that secretion of these factors is important for dissemination and colonization of S. aureus in infected animals. EsxA and EsxB are secreted by a specialized secretion system referred to as Ess, for ESAT-6 like secretion system. ESAT-6 ( early secreted an tigen of 6 kDa) was first identified along with genes required for its secretion in Mycobacterium tuberculosis. Although ESAT-6 like genes have been identified in the sequenced genomes of various Gram positive bacteria, the possibility that they might be elements of a new secretion system and contribute virulence strategies, had hitherto not been addressed.

Dr. Missiakas developed bursa aurealis, a mariner based transposon that is used to generate insertion mutations in S. aureus and B. anthracis. In particular, she used bursa aurealis to create the Phoenix library, a collection of 11,000 defined insertion mutants in S. aureus strain Newman. A total of 1,853 open reading frames have been disrupted to date i.e. 70% of all genes. Phoenix is used to identify factors required for infection, regulation of toxins, study dedicated pathways such Ess-dependent secretion, heme iron uptake or protein sorting and secretion in the envelope of staphylococci. Sorting of lipoproteins has been examined in details. The pathway for lipoprotein maturation in conserved in staphylococci. Lipoproteins are synthesized in the cytoplasm as precursors with an N-terminal signal peptide for secretion via the Sec pathway. Lipoprotein diacylglycerol transferase (Lgt) catalyzes transfer of phosphatidylglycerol to the sulfhydryl moiety of a cysteine residue conserved in the signal peptides of all lipoprotein precursors. Leader signal peptidase B (Lsp) cleaves acylated precursor lipoproteins to generate matured lipoproteins. The Phoenix library was used to examine the contribution of staphylococcal lipoproteins to immune recognition and disease pathogenesis. Binding of bacterial molecules called PAMPs for pathogen associated molecule patterns, to dedicated Toll-like receptors (TLRs) or Nod proteins triggers specific signaling events and host responses to invading pathogens. Among PAMPS are gram positive bacterial lipoproteins, peptidoglycan, lipotheichoic acid, teichoic acid. The Phoenix library was examined for mutants with defects in the biosynthesis of specific PAMPs. However, only transposon insertions in lgt and lsp were identified in the Phoenix collection as the other pathways for PAMPS biosynthesis are essential for bacterial growth. S. aureuslgt mutant variants bearing apo-lipoproteins were found to escape immune recognition and cause disseminated abscess formation with increased lethality during infection. Immune cells did not infiltrate sites of infection carrying these mutant bacteria in part because TLR-2 signaling did not occur and lgt mutants did not induce production of TNF-α, IL-1 or IL-6 during infection. S. aureuslsp mutant variants bearing uncleaved acylated lipoproteins were less virulent during infection. Hence, acylation of lipoproteins is required for initiating and sustaining effective immune responses during staphylococcal infection.

As a graduate student, Dr. Missiakas was awarded fellowships from the Ministère de la Recherche et de la Technologie (1987-1991) and from the Ministère de l’Education (1989-1990). In 1992, she was awarded a two-year postdoctoral fellowship from EMBO. She has received funding from the Swiss Fond National, French Medical Research Foundation, the CNRS, the National Institutes of Health, the American Heart Association and Argonne National Laboratory. Dr. Missiakas is currently a co-Investigator on an Anthrax research project in the Great Lakes Regional Center of Excellence in Biodefense based at the University of Chicago. Dr. Missiakas contributes to the Microbiology program by teaching Fundamentals of Bacterial Physiology, Molecular Genetic of Bacterial Pathogenesis and the Microbiology Seminar Series. She is the Undergraduate Advisor for the Microbiology program and serves as a mentor and a member of various thesis committees for Microbiology graduate students.

 

Department of Microbiology, CLSC 1117, 920 E. 58th St. Chicago, IL 60637

contact info microbiology@uchicago.edu